From: Children's vomiting following posterior fossa surgery: A retrospective study
Parameter | Â |
---|---|
Number of Patients | 249 |
Site n(%) | Â |
   Stollery Children's Hospital | 55 (22.1%) |
   Hospital for Sick Children | 194 (77.9%) |
Length of hospital stay in days (Mean ± SD, Range) | 11 (± 21, 2–305) |
Age in years (Mean ± SD, Range) | 7.6 ± 4.4, 0.3–-16.8 |
Age in Quartiles n(%) | Â |
   0 to <4 years | 65 (26.1%) |
   4 to <7 years | 61 (24.5%) |
   7 to < 12 years | 75 (30.1%) |
   12 to <17 years | 48 (19.3%) |
Male: Female (Ratio %) | 128 (51.4%):121 (48.6%) |
Surgery n(%) | Â |
   Brain Tumour | 153 (61.4%) |
   Chiari I Malformation | 81 (32.5%) |
   Other | 15 (6.0%) |
Chiari II Malformation | 7 (2.8%) |
Vascular Malformation | 4 (1.6%) |
Cyst or Aspiration of Pus | 4 (1.6%) |
Presenting with vomiting n(%) | 115 (46.2%) |
Preoperative Dexamethasone n(%)1 | 136 (54.6%) |
Intraoperative Ondansetron | 117 (47.0%) |
   Without Dexamethasone | 47 (18.9%) |
Intraoperative Dexamethasone | 131 (52.6%) |
   Without Ondansetron | 61 (24.5%) |
Intraoperative Ondansetron and Dexamethasone | 70 (28.1%) |
No intraoperative anti-emetic | 71 (28.5%) |
Length of surgery in hours (Mean ± SD, Range) | 5:01 ± 2:10 (1:39–17:56) |
Length of anaesthesia in hours (Mean ± SD, Range) | 6:22 ± 2:20 (2:05–20:15) |
Type of volatile anaesthetic n(%) | Â |
   Isoflurane | 126 (50.6%) |
   Desflurane | 46 (18.5%) |
   Isoflurane + Sevoflurane | 32 (12.9%) |
   Sevoflurane | 22 (8.8%) |
   Isoflurane + Desflurane | 8 (3.2%) |
   Sevoflurane + Desflurane | 2 (0.8%) |
   Not recorded/not legible | 13 (5.2%) |
Use of Nitrous Oxide** | 7 (2.8%) |
Received Postoperative Anti-emetic (%) | 199 (79.9%) |
Opioid administration initiated by the first 24 hours (%) | 228 (91.6%) |